Source: Drug Delivery and Translational Research. Unidades: FCFRP, FMRP
Subjects: NANOPARTÍCULAS, PSORÍASE, MEDICAMENTO TÓPICO, CITOCINAS, GENÉTICA, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEGAS, Juliana Santos Rosa et al. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. Drug Delivery and Translational Research, v. 10, n. 3, p. 646-660, 2020Tradução . . Disponível em: https://doi.org/10.1007/s13346-020-00723-6. Acesso em: 27 maio 2024.APA
Viegas, J. S. R., Praça, F. S. G., Caron, A. L., Suzuki, I. L., Silvestrini, A. V. P., Medina, W. S. G., et al. (2020). Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. Drug Delivery and Translational Research, 10( 3), 646-660. doi:10.1007/s13346-020-00723-6NLM
Viegas JSR, Praça FSG, Caron AL, Suzuki IL, Silvestrini AVP, Medina WSG, Del Ciampo LA, Kravicz MH, Bentley MVLB. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis [Internet]. Drug Delivery and Translational Research. 2020 ; 10( 3): 646-660.[citado 2024 maio 27 ] Available from: https://doi.org/10.1007/s13346-020-00723-6Vancouver
Viegas JSR, Praça FSG, Caron AL, Suzuki IL, Silvestrini AVP, Medina WSG, Del Ciampo LA, Kravicz MH, Bentley MVLB. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis [Internet]. Drug Delivery and Translational Research. 2020 ; 10( 3): 646-660.[citado 2024 maio 27 ] Available from: https://doi.org/10.1007/s13346-020-00723-6